EntryPoint Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$377K	Sell	11,951 -461	-4%	-$14.5K	0.19%	188
2025 Q1	$406K	Buy	+12,412	New	+$406K	0.19%	183
2024 Q2	–	Sell	-1,274	Closed	-$43.5K	–	1587
2024 Q1	$43.5K	Buy	+1,274	New	+$43.5K	0.04%	827